April 12, 2017

Largest Medicare Part D Provider Now Covers Auryxia for CKD Patients on Dialysis

News

Keryx Biopharmaceuticals announced that its phosphate binder Auryxia (ferric citrate) has been immediately added to the formularies for the country’s largest Medicare Part D plan provider. This will allow more unrestricted access to ... Read more

April 10, 2017April 10, 2017

On World Health Day, DaVita Partners with WHO to Address Depression in CKD Patients

News

DaVita Kidney Care, a division of Denver-based DaVita, partnered with the World Health Organization (WHO) on April 7 to address depression in patients with chronic kidney disease (CKD). World Health ... Read more

April 7, 2017

Kidney Health Goes Hollywood with Movie About a Transplant

News

The National Kidney Foundation has partnered with Warner Bros. to promote the release of a movie that draws long-overdue attention to kidney disease and organ donation. “Going in Style” is ... Read more

April 5, 2017

FDA to Review Auryxia for Patients with CKD and Iron Deficiency Anemia

News

Keryx Biopharmaceuticals’ drug Auryxia (ferric citrate) will undergo a review by the U.S. Food and Drug Administration (FDA) to expand its clinical indications to include non-dialysis dependent chronic kidney disease (NDD-CDK) ... Read more

April 3, 2017April 3, 2017

Cara’s Intravenous Therapy CR845 Reduces Itching in Uremic Pruritus Patients, Trial Finds

News

Cara Therapeutics announced that treatment with its intravenous drug CR845 reduced itching and improved quality of life in patients suffering from uremic pruritus (UP) associated with chronic kidney disease. These results come ... Read more

March 31, 2017

Positive Data Reported from Phase 2 Trials of Roxadustat for Treatment of Anemia in CKD

News

FibroGen, announced the publication of positive results from two Phase 2 clinical trials of roxadustat, its therapy candidate for the treatment of anemia in patients with chronic kidney disease (CKD). The study with ... Read more

March 29, 2017March 29, 2017

Vadadustat Eases Anemia in Chronic Kidney Disease Patients, Trial Shows

News

Akebia Therapeutics‘ vadadustat (AKB-6548) eased chronic kidney disease (CKD) patients’ anemia, a Phase 2a clinical trial showed. It did this by increasing levels of hemoglobin and improving iron mobilization in CKD patients ... Read more

March 27, 2017March 27, 2017

AAKP Awards Medal of Excellence to Philip Varughese of DaVita Kidney Care

News

The American Association of Kidney Patients (AAKP) has recognized Philip M. Varughese, a facility administrator for DaVita Kidney Care in Bound Brook, N.J., for his tireless advocacy on behalf of people ... Read more

March 24, 2017March 27, 2017

Yoga, Music, Raffles and KIDney Zone Planned for Sunday’s 2017 UCLA Kidney Health Fair

News

This year’s UCLA Kidney Health Fair, sponsored by the University of California, Los Angeles (UCLA), takes place Sunday, March 26. It kicks off with a talk by Anjay Rastogi, MD, PhD, director ... Read more

March 22, 2017

FDA Again Declines to Approve ZS-9 for Lowering Potassium in Blood

News

The U.S. Food and Drug Administration (FDA) has once again declined to approve AstraZeneca’s ZS-9 as a treatment for hyperkalemia, or high levels of potassium in the blood — a ... Read more

March 20, 2017March 20, 2017

Study Links 2 Genes to Glomerulonephritis, a Rare Kidney Disease

News

Researchers have identified two genes that contribute to a disease called glomerulonephritis, or acute kidney inflammation. Their study, “GWAS for serum galactose-deficient IgA1 implicates critical genes of the O-glycosylation pathway”, appeared in ... Read more

March 17, 2017March 17, 2017

Magnesium Supplements Help Obese Kidney Disease Patients, Clinical Trial Shows

News

Magnesium supplements helped chronic kidney disease patients who were obese and had low magnesium levels improve their insulin-resistance and disease profiles, clinical trial results showed. The supplements also led to ... Read more

March 15, 2017

CKD Patients Don’t Benefit from Intensive Blood Pressure Control, Study Says

News

Blood pressure treatment below the standard accepted level does not offer an additional benefit for renal function in patients with chronic kidney disease (CKD) without diabetes, according to researchers. However, ... Read more

March 13, 2017

World Kidney Day Sheds Light on Obesity’s Link to CKD

News

Obesity is a major risk factor for chronic kidney disease (CKD) as well as kidney failure, three researchers wrote in an editorial aiming to put the spotlight on the issue for ... Read more

March 10, 2017

Parsabiv Approved in Europe for Secondary Hyperparathyroidism in Adults on Hemodialysis

News

The European Commission (EC) has granted marketing authorization for Parsabiv (etelcalcetide), Amgen’s candidate for treating secondary hyperparathyroidism (sHPT) in adult patients with chronic kidney disease (CKD) who are undergoing hemodialysis. Parsabiv is a ... Read more

March 8, 2017March 8, 2017

March 9 is World Kidney Day: Join the Global Awareness Campaign

News

March 9 is World Kidney Day, an event that since 2006 has raised awareness about kidney health and chronic kidney disease (CKD). Hundreds of events take place worldwide, from public screenings ... Read more

March 6, 2017

CKD Patients Have Higher Out-of-Pocket Expenses in US Than Cancer, Study Shows

News

U.S. patients with chronic kidney disease (CKD) who are not dependent on dialysis have high or higher out-of-pocket expenses than other costly diseases such as cancer and stroke. In addition, ... Read more

March 3, 2017March 3, 2017

Gene Variations May Help Explain Severity of Many African-Americans’ Kidney Disease

News

Variants of a gene called APOL1 may be linked to an increased risk of kidney disease, researchers at the University of Pennsylvania found. This could explain why chronic and end-stage ... Read more

March 1, 2017

CMHP Favors Approval of AstraZeneca’s Lokelma to Treat Hyperkalemia in Europe

News

Europe’s Committee for Medicinal Products for Human Use (CMPH) has recommended approving AstraZeneca’s Lokelma for the treatment of hyperkalemia (high levels of potassium in the blood), a condition common in patients with chronic kidney ... Read more

February 27, 2017February 27, 2017

Resverlogix Plans Phase 2a Kidney Dialysis Trial of Apabetalone in 2017

News

Resverlogix said it will move ahead with its Phase 2a kidney dialysis trial following a Type B meeting with the Cardiovascular and Renal Products Division of the U.S. Food and Drug Administration ... Read more